The EMA has posted the press release with details of the CVMP's meeting of 2 – 4 June 2015 (Link). General news relating to regulatory affairs includes:
The Committee adopted a concept paper on the testing strategy and risk assessment for plants in Phase II of the environmental risk assessment for veterinary medicinal products for a 3-month period of public consultation.
The Committee adopted the latest combined VeDDRA list of clinical terms for reporting suspected adverse reactions to veterinary medicinal products, following the yearly review and update.
The Committee adopted a reflection paper on the use of cocrystals of active substances in medicinal products and overview of comments following the close of the public consultation.
